| Fourth
Round Proposals funded - October 2004
Pilot and Development
funds were awarded to the following groups:-
Dr
Michael Threadgill, University of Bath
"Optimisation of
linkers in a polymeric prodrug system for selective prostate delivery
of drugs"
Dr
Matthew Lloyd, University of Bath
"The molecular role
of a-methylacyl-Coa racemase in prostatic cancer"
Dr
Christopher Bunce, University of Birmingham
"Targeting peroxisome
proliferation activator receptors (PPARs) in prostate carcinoma"
Third Round Proposals
funded- August 2003
Pilot and Development
funds were awarded to the following groups:-
Professor Gwyn Williams,
Keele University
"Molecular mechanisms
of cell death: development of prostate cell lines for functional
identification of apoptosis genes"
Dr Robert Kypta,
Imperial College London
"The effects of purified
Wnt proteins on prostate cell growth and differentiation"
Dr Janet Shipley,
ICR, Sutton, Surrey
"Expression profiling
laser capture microdissected prostate tissues"
Dr Youqiang Ke,
University of Liverpool
"Preliminary investigation
of possible mechanism of the tumourigenicity-suppressing activity
of TIG1 in prostate cancer cells"
Download Call for
Proposals (Word document 25KB)
Download the application
form (Word document 74 KB)
Second
Round Proposals funded - Oct 2002
23 applications were received at the Collaborative meeting on 25th
October and the decision was taken to offer funding to the top two
alpha*:
Dr Axel Thomson
at the MRC Human Reproductive Sciences Unit, Edinburgh
"Identification of mesenchymal genes involved in prostatic
growth using SAGE analysis"
Dr Ermanno Gherardi
at the University of Cambridge
"MET antagonists for cancer therapy"
Following a review of the "runners up" applications from
the JANUARY 2002 and OCTOBER 2002 two further awards have been made:
Dr
Moray Campbell, University of Birmingham Medical School "Gene
re-expression chemoprevention strategies in prostae cancer"
Prof Mustafa
Djamgoz at Imperial College, London
"A possible secretory system operating in positive feed-back
mode to accelerate metastatic prostate cancer"
First
Round Proposals funded - Jan 2002
Pilot and Development funds were awarded to the following groups:-
Professor Freda Stevenson University
of Southampton
“DNA gene fusion vaccines against prostate cancer”
Dr Chris Parker Royal
Marsden NHS Trust
“A study of tumour microenvironment in localised prostate
cancer managed by surveillance”
Professor Dave Phillips
Institute of Cancer Research
“Environmental factors in prostate cancer”
Awarded use of Core Collaborative Resources for the production
of tissue arrays:-
Professor
Jack Cuzick Imperial
Cancer Research Fund
“Molecular markers as prognostic factors in clinically localized
prostate cancer: creation of a resource”
|